Which statement best describes a myasthenic crisis management?

• A. It is always a life-threatening emergency requiring intubation
• B. It is caused by MG worsening.
• C. It improves with anticholinergic withdrawal
• D. It is managed with neostigmine and anticholinergics, with monitoring

Answer: (D)

In this situation the best approach focuses on improving neuromuscular transmission and keeping the patient safe to breathe. A myasthenic crisis happens when there’s not enough acetylcholine activity at the neuromuscular junction, so the treatment goal is to boost acetylcholine levels with an acetylcholinesterase inhibitor like neostigmine. This helps strengthen the weakened muscles, including those involved in breathing. At the same time, anticholinergics are given to counter the muscarinic side effects of neostigmine (such as bradycardia or excessive secretions), so the regimen is balanced to improve function while managing side effects. Continuous monitoring is essential because the situation can swing toward respiratory failure, and you may need to escalate care with ventilatory support or other therapies if weakness worsens. This combination—enhancing acetylcholine to improve strength, using an anticholinergic to modulate side effects, and closely watching respiratory status—embodies the appropriate management for a myasthenic crisis.